Modern Healthcare writes of an Institute for Clinical and Economic Review (ICER) project that will compare the cost and benefit of costly drugs. ICER will begin releasing reports that will compare clinical effectiveness of drugs, compare prices and their potential impact on the U.S. healthcare system and economy. The agency will then set a value-based benchmark for pricing. The ICER project is funded by a $5.2 million grant from the Laura and John Arnold Foundation, a private foundation that encourages evidence-based and multidisciplinary approaches to address challenges in various sectors, including education, policy and healthcare. The reports will reference how prices are directly linked to the drugs’ ability to improve the health of patients.
Project Announced to Compare Cost, Benefit of Costly Drugs
More from United StatesMore posts in United States »
- Oklahoma House of Reps Passes Bill for Greater Health Care Price Transparency
- AHRQ Stats: Hospitalization for Cancer
- Study Finds Employer-Provider Direct Payment Program Associated With Lower Episode Costs
- Study Finds National Heart Failure Hospitalizations Increased From 2014 Onwards
- Consumer Survey Reveals Worries About Rising Health Care Costs